Medicine-associated dementia and cognitive impairment: identifying the problem, reducing the harm

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1101788

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Several studies have shown an association between use of anticholinergic or sedative medicines and increased risk of dementia. Questions remain about whether these medicines cause dementia (or are just used by people already at risk), whether or not cognitive function improves if the medicines are stopped or if the dose is reduced, and the characteristics of patients most likely to use these medicines. This program of research aims to answer these questions.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2021

Funding Scheme: Targeted Calls

Funding Amount: $513,116.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adverse effects | dementia | health promotion | pharmacoepidemiology | quality use

Related Links